[go: up one dir, main page]

MXPA02004770A - Composiciones terapeuticas y metodos para su uso. - Google Patents

Composiciones terapeuticas y metodos para su uso.

Info

Publication number
MXPA02004770A
MXPA02004770A MXPA02004770A MXPA02004770A MXPA02004770A MX PA02004770 A MXPA02004770 A MX PA02004770A MX PA02004770 A MXPA02004770 A MX PA02004770A MX PA02004770 A MXPA02004770 A MX PA02004770A MX PA02004770 A MXPA02004770 A MX PA02004770A
Authority
MX
Mexico
Prior art keywords
methods
therapeutic compositions
therapeutic
compositions
Prior art date
Application number
MXPA02004770A
Other languages
English (en)
Inventor
Milton Hodosh
Original Assignee
Milton Hodosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/439,858 external-priority patent/US6099868A/en
Application filed by Milton Hodosh filed Critical Milton Hodosh
Publication of MXPA02004770A publication Critical patent/MXPA02004770A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA02004770A 1999-11-12 2000-11-13 Composiciones terapeuticas y metodos para su uso. MXPA02004770A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/439,858 US6099868A (en) 1999-11-12 1999-11-12 Method of using potassium nitrate for pain reduction
US09/633,424 US6524623B1 (en) 1999-11-12 2000-08-07 Therapeutic compositions and methods of use thereof
PCT/US2000/031086 WO2001034165A1 (en) 1999-11-12 2000-11-13 Therapeutic compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
MXPA02004770A true MXPA02004770A (es) 2003-10-14

Family

ID=27032197

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004770A MXPA02004770A (es) 1999-11-12 2000-11-13 Composiciones terapeuticas y metodos para su uso.

Country Status (8)

Country Link
US (2) US6524623B1 (es)
EP (1) EP1227821A4 (es)
JP (1) JP2003521482A (es)
AU (1) AU777821B2 (es)
BR (1) BR0015478A (es)
CA (1) CA2391278A1 (es)
MX (1) MXPA02004770A (es)
WO (1) WO2001034165A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372150C (en) 1999-04-30 2011-08-30 The Regents Of The University Of Michigan Therapeutic applications of pro-apoptotic benzodiazepines
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7144880B2 (en) * 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
US20040176358A1 (en) * 1999-04-30 2004-09-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
EA011309B1 (ru) * 2000-06-13 2009-02-27 Вайет Составы для ослабления боли, содержащие целекоксиб
US8900607B1 (en) * 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
GB0315269D0 (en) * 2003-07-01 2003-08-06 Maleno Idalecio B F Mouth and/or throat wash
US20050272723A1 (en) * 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
EP1776083A4 (en) * 2004-07-02 2010-06-02 Discus Dental Llc SENSITIVITY-RELATED TOOTH COMPOSITIONS
EP2359842A1 (en) 2004-07-14 2011-08-24 University of Utah Research Foundation Netrin-related compositions and uses
US20060052369A1 (en) * 2004-09-07 2006-03-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
AU2006203946B2 (en) 2005-01-03 2009-07-23 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2006080924A1 (en) * 2005-01-27 2006-08-03 C.B. Fleet Company Incorporated Feminine anti-itch gel
JP2008545757A (ja) 2005-06-01 2008-12-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 溶媒和されていないベンゾジアゼピン組成物および方法
EP1948191B1 (en) 2005-11-01 2013-01-16 The Regents of the University of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) * 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
EP2418206A3 (en) 2006-06-09 2012-06-27 The Regents of the University of Michigan Benzodiazepine derivatives useful in the treatment of autoimmune disorders
JP5383513B2 (ja) 2007-03-09 2014-01-08 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 化合物およびその標的に関連する組成物ならびに方法
WO2009036175A2 (en) 2007-09-14 2009-03-19 The Regents Of The University Of Michigan F1f0-atpase inhibitors and related methods
AU2008323945B2 (en) 2007-11-06 2013-11-28 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
JP2013505258A (ja) 2009-09-18 2013-02-14 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ベンゾジアゼピノン化合物およびそれを使用する治療方法
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
JP5856063B2 (ja) 2009-11-17 2016-02-09 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物
CN102753544A (zh) 2009-11-17 2012-10-24 密执安大学评议会 具有治疗性能的1，4-苯并二氮杂*-2，5-二酮和相关化合物
TWI816417B (zh) 2013-12-24 2023-09-21 維吉尼亞聯邦大學 氧化膽固醇硫酸鹽（ｏｃｓ）之用途
US20150297508A1 (en) * 2014-04-21 2015-10-22 William Andriette Topical Formulation to Enhance Genital Sensation and Function
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
US10597402B2 (en) 2015-03-27 2020-03-24 Sytheon Limited Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases
CN112022725B (zh) * 2020-09-10 2022-09-20 昆明蓝橙口腔医院有限责任公司 柠檬酸金属盐在根管治疗中的应用以及配制得到的制剂
US20240398678A1 (en) * 2021-11-22 2024-12-05 SkyLab AG Novel use of rochelle salt

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060600A (en) 1972-10-26 1977-11-29 National Patent Development Corporation Treating teeth
US3863006A (en) 1973-01-29 1975-01-28 Milton Hodosh Method for desensitizing teeth
US4191750A (en) 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4407675A (en) 1980-03-03 1983-10-04 Milton Hodosh Composition for preserving dental pulp
US4343608A (en) 1980-03-03 1982-08-10 Milton Hodosh Compound and method for preserving dental pulp
US4383986A (en) * 1981-08-17 1983-05-17 Ortho Pharmaceutical Corporation Hemorrhoidal compositions
US4400373A (en) 1981-12-15 1983-08-23 Milton Hodosh Method for treating gingival and periodontal tissues
DE3314895A1 (de) 1983-04-25 1984-10-25 Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz Zahn- und mundpflegemittel
FI75734C (fi) 1984-12-18 1988-08-08 Lilius Kaj Rainer Munskoeljningsloesning.
US4627976A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4610871A (en) 1984-12-21 1986-09-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627980A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Hard candy dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce irritation and plaque accumulation
US4632937A (en) 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627975A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dental floss dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627979A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Toothpaste dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627974A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4610872A (en) 1984-12-21 1986-09-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4585649A (en) 1984-12-21 1986-04-29 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627978A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Tooth drop dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
EP0227826B1 (en) 1985-08-02 1989-10-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US4711904A (en) * 1986-08-04 1987-12-08 Luzzi Louis A Method of treating skin disorders
JPS6445308A (en) 1987-08-12 1989-02-17 Yasuhiro Asai Dental cleaning material
US4770871A (en) 1987-11-06 1988-09-13 Ici Americas Inc. Process for the preparation of dianhydrosorbitol ethers
US4961923A (en) 1988-02-19 1990-10-09 Dentsply Management Corp. Irrigants for use in scaling and/or lavage apparatus
US5139768A (en) 1989-01-31 1992-08-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
US5015466A (en) * 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
US5147632A (en) 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
US5153006A (en) 1991-08-12 1992-10-06 Milton Hodosh Method of treating post-restoration dental pain
US5374417A (en) 1991-10-17 1994-12-20 Colgate Palmolive Company Desensitizing dentifrice
IL112649A (en) * 1994-02-22 1999-12-22 Curtis Helene Ind Inc Topically effective compositions for application to the skin or hair
US5522726A (en) 1994-10-27 1996-06-04 Hodosh; Milton Method for anesthetizing teeth
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
FR2774595A1 (fr) * 1998-02-06 1999-08-13 Rech D Innovation Et De Dev Ce Emulsion pour l'administration transdermique de steroides
US6032388A (en) * 1998-05-01 2000-03-07 Puma Ag Rudolf Dassler Sport Thin, flexible shoe outsole with injected-through tread elements, a method of producing such an outsole and a shoe provided with such an outsole
ID30353A (id) * 1999-02-05 2001-11-22 Cipla Ltd Obat semprot topikal
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
US6099868A (en) * 1999-11-12 2000-08-08 Hodosh; Milton Method of using potassium nitrate for pain reduction

Also Published As

Publication number Publication date
AU1657201A (en) 2001-06-06
CA2391278A1 (en) 2001-05-17
US6524623B1 (en) 2003-02-25
EP1227821A1 (en) 2002-08-07
EP1227821A4 (en) 2004-09-22
AU777821B2 (en) 2004-11-04
US7115252B2 (en) 2006-10-03
JP2003521482A (ja) 2003-07-15
WO2001034165A1 (en) 2001-05-17
BR0015478A (pt) 2004-04-27
US20030003163A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
FI991485A0 (fi) Uusi farmaseuttinen koostumus
DE60045324D1 (de) Impfstoffzusammensetzung
PT1060695E (pt) Cadeira empilhavel
PT1237408E (pt) Formulacoes para derramar
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
AR028398A1 (es) Ciclipostinas, procedimiento para su preparacion, y utilizacion de las mismas
AR025230A1 (es) Procedimiento para preparar fosfonometilglicina.
DE59905993D1 (de) Abschaltkupplung
ATA90082000A (de) Sitzmöbel
NO20023003L (no) Benzofenon-glykopyranosider, samt fremstilling og terapeutisk anvendelse
ES1042871Y (es) Pieza para colchones y similares.
BR7903360Y1 (pt) cadeira para uso obstÉtrico.
SE9904414D0 (sv) Pharmaceutical composition and use
ATE252549T1 (de) Aminobutyronitril mischung
ATA36099A (de) Stoffgemisch
ES1044311Y (es) Borrador perfeccionado para encerados y pizarras.
ES1045216Y (es) Plataforma giratoria para centros ludicos y similares.
ATA14322000A (de) Absperrvorrichtung
ES1047538Y (es) Estructura perfeccionada para ventanas y similares.
SE0004405D0 (sv) New composition and use

Legal Events

Date Code Title Description
FG Grant or registration